(Q37980388)

26 August 2017

title

How to manage HIV-infected patients with chronic kidney disease in the HAART era. (English)

1 reference

chronic renal insufficiency

26 August 2017

main subject

1 reference

Minoru Ando

1

1 reference

26 August 2017

Ken Tsuchiya

series ordinal

2

1 reference

26 August 2017

Kosaku Nitta

series ordinal

3

1 reference

26 August 2017

publication date

1 June 2012

1 reference

Clinical and experimental nephrology

26 August 2017

published in

1 reference

26 August 2017

volume

16

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

363-372

1 reference

Survival of persons with and without HIV infection in Denmark, 1995-2005.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Prevalence of chronic kidney disease in Chinese HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Clinical characteristics of kidney disease in Japanese HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Chronic renal failure among HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Prevalence of chronic kidney disease in an urban HIV infected population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Predicting initiation and progression of chronic kidney disease: Developing renal risk scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

National surveillance of dialysis-associated diseases in the United States, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Racial differences in early-onset renal disease among young adults: the coronary artery risk development in young adults (CARDIA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Predictors of proteinuria and renal failure among women with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Chronic kidney disease in HIV infection: an urban epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Microalbuminuria in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Recent progress in HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

The nephrotoxic effects of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Renal function with use of a tenofovir-containing initial antiretroviral regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Low molecular weight proteinuria in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Urinary NGAL marks cystic disease in HIV-associated nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Revised equations for estimated GFR from serum creatinine in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Prevalence of chronic kidney disease in the Japanese general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Cystatin C and mortality risk in the elderly: the health, aging, and body composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Factors other than glomerular filtration rate affect serum cystatin C levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Predictors of Renal Outcome in HIV‐Associated Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Poor Validity of Urine Dipstick as a Screening Tool for Proteinuria in HIV-Positive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10157-012-0585-7

Racial/ethnic disparities in prevalence, treatment, and control of hypertension--United States, 1999-2002

21 January 2018

1 reference

12 December 2020

Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis

1 reference

12 December 2020

Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients

1 reference

12 December 2020

Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients.

1 reference

12 December 2020

Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy

1 reference

12 December 2020

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

12 December 2020

A simple model for predicting incidence of chronic kidney disease in HIV-infected patients

1 reference

12 December 2020

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

1 reference

12 December 2020

Screening for chronic kidney disease in the ambulatory HIV population.

1 reference

12 December 2020

Relationship between hepatitis C and microalbuminuria: results from the NHANES III

1 reference

12 December 2020

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

Early detection of progressive chronic kidney disease: is it feasible?

1 reference

12 December 2020

Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality

1 reference

12 December 2020

Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy

1 reference

12 December 2020

Is there an epidemic of HIV Infection in the US ESRD program?

1 reference

12 December 2020

Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study

1 reference

12 December 2020

10.1007/S10157-012-0585-7

Identifiers

DOI

1 reference

26 August 2017

1 reference